Here's how analysts read the market pulse: “Global markets are still grappling with the impact of the US rating downgrade, with spiking bond yield and strengthening dollar index. However, the pharma sector has managed to weather the storm — thanks to its strong earnings outcome, while mid- and small-cap stocks have outperformed the benchmark index,” said Vinod Nair, Head of Research at Geojit Financial Services. «Nifty slipped further as the bears continued to remain at the helm.
The index fell sharply following a breakdown below 19500. However, 19300 acted as support on a sustained basis for the day. Going forward, 19300 may act as crucial support, while, on the higher end resistance is seen at 19500/19650,» said Rupak De, Senior Technical analyst at LKP Securities.
That said, here’s a look at what some key indicators are suggesting for Friday’s action:US market Wall Street's main indexes slipped on Thursday as a jump in bonds yields, a mixed bag of corporate earnings and a slew of economic data pointing to stubborn inflation kept investors on edge. Market participants have been keeping a close watch on data as they fear the Federal Reserve may stick to its rate hike path if it fails to bring inflation within its targeted range. At 10:08 a.m.
ET, the Dow Jones Industrial Average was down 63.64 points, or 0.18%, at 35,218.88, the S&P 500 was down 15.69 points, or 0.35%, at 4,497.70, and the Nasdaq Composite was down 30.67 points, or 0.22%, at 13,942.78.European sharesEuropean stocks hit a three-week low on Thursday, hurt by disappointing earnings reports, elevated U.S. bond yields and data pointing to slowing business activity in the euro zone. The pan-European STOXX 600 index fell 0.9%, its third consecutive day of
. Read more on economictimes.indiatimes.com